4 withdrawn, 3 unknown, 2 completed, 1 active not recruiting. 11 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Withdrawn 4, Unknown 3, Completed 2, Active not recruiting 1, Terminated 1 |
| Phase 2 | 4 | Withdrawn 2, Active not recruiting 1, Completed 1 |
Follow Facial Neuralgia: new trials by email Literature Review of Facial Neuralgia trials Research Report on Facial Neuralgia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Botulinum Toxin A in Patients With Trigeminal Neuralgia Botulinum toxin A, Isotonic saline - Trigeminal Neuralgia | Phase 3 | Unknown | Henrik Schytz | 80 | 2023-11-01 | 2024-03-18 |
| 802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia BIIB074, Placebo - Trigeminal Neuralgia | Phase 3 | Withdrawn | Biogen | 2023-04-19 | 2023-05-06 | |
| 802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia BIIB074, Placebo - Trigeminal Neuralgia | Phase 3 | Withdrawn | Biogen | 2023-03-01 | 2023-05-06 | |
| An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. Basimglurant, Placebo - Trigeminal Neuralgia | Phase 2 / Phase 3 | Active not recruiting | Noema Pharma AG | 166 | 2022-01-11 | 2026-01-23 |
| SPG Block for Acute Pediatric Migraine Lidocaine topical, Prochlorperazine Injection - Migraine in Children, Sphenopalatine Neuralgia | Phase 3 | Unknown | Newark Beth Israel Medical Center | 72 | 2019-06-06 | 2021-11-17 |
| Botulinum Toxin Injections for Oral Neuropathic Pain BOTOX®, Allergan, Placebo - Trigeminal Neuropathy, Traumatic | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 43 | 2019-04-04 | 2023-04-10 |
| Botulinum Toxin for Trigeminal Neuralgia Botulinum Toxin type A (intradermal / submucosal injection at pain area), Botulinum Toxin type A (intra-masseter injection on the ipsilateral of pain involved) - Trigeminal Neuralgia | Phase 3 | Unknown | The First Affiliated Hospital of Zhengzhou University | 150 | 2017-11-07 | 2018-11-26 |
| Efficacy and Safety of ATNC05 in Treatment of Atypical Facial Pain ATNC05, Placebo - Atypical Facial Pain, Persistent Idiopathic Facial Pain | Phase 2 / Phase 3 | Withdrawn | Allodynic Therapeutics, Inc | 2014-03-01 | 2014-03-13 | |
| A Study of Amifostine for Prevention of Facial Numbness in Radiosurgery Treatment of Trigeminal Neuralgia Amifostine, CyberKnife stereotactic radiosurgery - Trigeminal Neuralgia | Phase 3 | Terminated | Stanford University | 17 | 2008-09-01 | 2017-04-04 |
| Efficacy and Safety Study of Lamotrigine to Treat Trigeminal Neuralgia Lamictal®, Tegretol® - Trigeminal Neuralgia | Phase 2 / Phase 3 | Completed | University of Malaya | 21 | 2007-09-01 | 2010-06-29 |
| Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception laboratory pain assessment, transcranial magnetic stimulation - Pain, Trigeminal Neuralgia | Phase 2 / Phase 3 | Withdrawn | Medical University of South Carolina | 2006-07-01 | 2012-04-30 |
Trigeminal Neuralgia (9) · Chronic Pain (1) · Complex Regional Pain Syndromes (1) · Facial Pain (1) · Neuralgia (1) · Pain (1) · Reflex Sympathetic Dystrophy (1) · Trigeminal Nerve Injuries (1)
Cranial Nerve Diseases (11) · Facial Nerve Diseases (11) · Mouth Diseases (11) · Nervous System Diseases (11) · Stomatognathic Diseases (11) · Trigeminal Nerve Diseases (10) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autonomic Nervous System Diseases (1) · Cranial Nerve Injuries (1) · Craniocerebral Trauma (1) · Neuromuscular Diseases (1) · Pain (1)
Botulinum Toxins, Type A (3) · vixotrigine (2) · 2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine (1) · Amifostine (1) · Carbamazepine (1) · Injections, Intradermal (1) · Lamotrigine (1) · Lidocaine (1) · Prochlorperazine (1) · Radiosurgery (1) · Sodium Chloride (1) · Transcranial Magnetic Stimulation (1)
Biogen (2) · Allodynic Therapeutics, Inc (1) · Assistance Publique - Hôpitaux de Paris (1) · Henrik Schytz (1) · Medical University of South Carolina (1) · Newark Beth Israel Medical Center (1) · Noema Pharma AG (1) · Stanford University (1) · The First Affiliated Hospital of Zhengzhou University (1) · University of Malaya (1)
United States (5) · Denmark (2) · China (1) · France (1) · Germany (1) · Italy (1) · Malaysia (1) · Poland (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Adam Sivitz, MD (1) · Chuanjie Wu, MD (1) · Clara Choi (1) · Dr. Sameer Shaikh, MDSc. (1) · Jeffrey J. Borckardt, Ph.D. (1) · Scott Soltys (1)
2016 (2), 2017 (1), K23NS050485 (1)